Liraglutide (Victoza, Saxenda): Digestive Effects
Share
Short answer: Liraglutide is a GLP-1 receptor agonist given as a once-daily injection, marketed as Victoza and Saxenda for different approved uses. Like other GLP-1 medications it commonly causes nausea, diarrhea or constipation, especially during dose increases. Your prescriber can explain how it compares with weekly options.
Written by the Along team at Along Labs LLC. Last updated . 5 minute read.
Key takeaways
- Type: GLP-1 receptor agonist
- Dosing: once daily injection
- Brands: Victoza, Saxenda
- Effects: nausea, diarrhea, constipation
- Ask: how it compares with weekly options
In this article
- What is liraglutide?
- What digestive effects occur?
- How does it differ from weekly options?
- When should you talk to your doctor?
- Frequently asked questions
What is liraglutide?
An older GLP-1 medication given daily. Brand names have different approved uses. See what is a GLP-1 medication?.
What digestive effects occur?
Nausea, vomiting, diarrhea, constipation and indigestion are common, particularly early on. See indigestion on GLP-1 medications and vomiting.
How does it differ from weekly options?
Daily dosing means a more frequent routine. Compare in semaglutide vs tirzepatide and dose escalation explained.
When should you talk to your doctor?
This article is general education, not medical advice. Always follow your prescriber's instructions and the medication label, and contact your clinician about symptoms that are severe, persistent or worrying.
Frequently asked questions
Is liraglutide still used?
Yes, it remains prescribed in many places.
Does it cause the same side effects as semaglutide?
Many are similar.
Is Victoza the same as Saxenda?
They contain the same active ingredient with different labeling.
Related reading
- Why GLP-1 medications cause constipation, bloating and nausea
- Semaglutide vs Tirzepatide: Digestive Differences
- Dose Escalation Explained: Why Doses Increase Slowly
- Stomach Pain on GLP-1 Medications: What to Know
- What Is a GLP-1 Medication? A Plain-Language Guide
Sources and further reading
- National Institute of Diabetes and Digestive and Kidney Diseases: Digestive diseases
- DailyMed (U.S. National Library of Medicine): prescribing information for GLP-1 medications
This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.